Results 81 to 90 of about 4,386 (137)

Corticosteroid Receptor Modulation in the Dorsal Striatum Prevents Morphine‐Induced Place Preference and Reduction in Dopamine Transporter (DAT) Immunoreactivity in Rats

open access: yesAddiction Biology, Volume 31, Issue 9, September 2026.
Intra‐dorsal striatal corticosterone attenuated morphine‐induced CPP. GR and MR antagonists also attenuated morphine‐induced CPP. Morphine reduced DAT immunoreactivity, an effect prevented by CORT and antagonists. Distinct corticosteroid manipulations converged on similar reward and DAT outcomes.
Payman Raise‐Abdullahi   +6 more
wiley   +1 more source

Immunomodulatory Effects of Tokishakuyakusan on Progesterone Withdrawal–Induced Uterine Inflammation in Pregnant Mice

open access: yesAmerican Journal of Reproductive Immunology, Volume 96, Issue 3, September 2026.
ABSTRACT Problem Tokishakuyakusan (TSS) is a traditional Japanese Kampo medicine widely used to support pregnancy; however, its molecular mechanisms remain poorly understood. This study aimed to elucidate the progesterone‐related immunomodulatory mechanisms underlying the pregnancy‐supportive effects of TSS using a mouse model of progesterone ...
Takeshi Nagamatsu   +8 more
wiley   +1 more source

Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial

open access: yes, 2015
Josep Lluis Carbonell,1 Ramon Garcia,2 Adriana Gonzalez,2 Andres Breto,2 Carlos Sanchez2 1Mediterranea Medica Clinic, Valencia, Spain; 2Eusebio Hernandez Gynecology and Obstetrics Teaching Hospital, Havana, Cuba Purpose: To estimate the efficacy and ...
Carbonell JL   +4 more
core  

Randomly Albright: The End of Judge Shopping in the Western District of Texas?

open access: yesJournal of Empirical Legal Studies, Volume 23, Issue 3, Page 327-346, September 2026.
ABSTRACT Because judges exercise discretion in how they handle and decide cases, heterogeneity across judges can affect case outcomes and, thus, preferences among litigants for particular judges. However, selection obscures the causal mechanisms that drive these preferences.
Christian Helmers   +2 more
wiley   +1 more source

Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery

open access: yes, 2012
Josep L Carbonell Esteve1, Ana M Riverón2, Mariela Cano2, Alma I Ortiz3, Aleta Valle2, Carlos S Texidó2, Giuseppe Tomasi41Mediterránea Médica Clinic, Valencia, Spain; 2Eusebio Hernández Obstetrics ...
Ortiz AI   +6 more
core  

What is the impact of contraceptive methods and mixes of contraceptive methods on contraceptive prevalence, unmet need for family planning, and unwanted and unintended pregnancies? [PDF]

open access: yes, 2013
Background - In many low-and middle-income countries, there is high maternal, infant and child mortality due in part to low contraceptive use and high unmet need for family planning.
Ogollah, Reuben   +13 more
core  

Exploring the Journey of Mifepristone in Canada and Australia

open access: yes, 2020
Mifepristone, also known by its drug development name RU486, is an anti-progestin that is part of the gold standard regimen of medication abortion. This medication is taken orally to induce an abortion through 70 days after the first day of the pregnant ...
LaRoche, Kathryn J.
core   +1 more source

Zebrafish as a practical and convenient model for the study of photodynamic and photothermal therapy of solid tumors: A scoping review

open access: yesPhotochemistry and Photobiology, Volume 102, Issue 5, Page 1060-1078, September/October 2026.
Zebrafish provide a high‐throughput, optically transparent platform for cancer and drug screening. Their ~80% genetic homology, xenograft compatibility, and transgenic strains enable targeted photosensitizer screening, real‐time ROS and tumor imaging, and mechanistic assays, while fish embryo acute toxicity (FET) and in vitro tests streamline toxicity ...
Ethan Wilson   +5 more
wiley   +1 more source

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity

open access: yesCancer Cell International, 2009
Background The prototypical antiprogestin mifepristone exhibits potent growth inhibition activity towards ovarian cancer cells in vitro and in vivo.
Seidel Erin E   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy